Baudax Bio Current Ratio 2011-2026 | BXRX

Annual Current Ratio Baudax Bio

2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
0.293	1.33	2.03	2.61	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
2.61	0.293	1.56

Quarterly Current Ratio Baudax Bio

2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
0.94	0.93	0.49	0.29	0.47	1.12	1.25	1.33	0.75	0.94	0.99	0.82	0.82	0.82	0.82	0.76	0.76	0.76	0.76	0.34	0.34	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
1.33	0.29	0.786

Current Ratio of other stocks in the Biotechnology industry

Issuer	Current Ratio	Price	% 24h	Market Cap	Country
MorphoSys AG MOR	1.02	-	2.43 %	$ 254 M	Germany
Assembly Biosciences ASMB	5.07	$ 30.08	5.69 %	$ 337 M	USA
Ascendis Pharma A/S ASND	0.889	$ 223.99	0.95 %	$ 5 B	Danmark
Autolus Therapeutics plc AUTL	2.2	$ 1.41	2.55 %	$ 360 M	Britain
Axsome Therapeutics AXSM	1.15	$ 158.23	0.83 %	$ 7.87 B	USA
I-Mab IMAB	8.96	-	-	$ 866 M	China
Alexion Pharmaceuticals, Inc. ALXN	3.59	-	-	$ 40.3 B	USA
Genfit SA GNFT	0.922	-	2.54 %	$ 160 B	France
Biophytis SA BPTS	1.34	-	-13.47 %	$ 169 M	France
Gilead Sciences GILD	3.1	$ 138.83	1.18 %	$ 173 B	USA
Galmed Pharmaceuticals Ltd. GLMD	6.37	$ 0.58	-3.33 %	$ 540 K	Israel
Midatech Pharma plc MTP	2.29	-	-18.52 %	$ 27.3 M	Britain
EyeGate Pharmaceuticals, Inc. EYEG	1.02	-	-1.52 %	$ 24.7 M	USA
Applied Genetic Technologies Corporation AGTC	1.79	-	-	$ 26.5 M	USA
ARCA biopharma ABIO	28.7	-	1052.0 %	$ 415 M	USA
Aeterna Zentaris AEZS	1.6	-	5.93 %	$ 314 M	Canada
AgeX Therapeutics AGE	1.81	-	-10.17 %	$ 12.2 K	USA
Acorda Therapeutics ACOR	1.61	-	-24.86 %	$ 820 K	USA
Albireo Pharma ALBO	2.39	-	-0.23 %	$ 916 M	USA
Aileron Therapeutics ALRN	7.98	-	10.36 %	$ 9.8 M	USA
Acasti Pharma ACST	13.4	-	4.01 %	$ 150 M	Canada
Институт стволовых клеток человека ISKJ	1.04	-	-	-	Russia
Grifols, S.A. GRFS	1.67	$ 7.75	2.24 %	$ 6.83 B	Spain
Avenue Therapeutics ATXI	3.27	-	-52.27 %	$ 4.45 M	USA
Adverum Biotechnologies ADVM	1.65	-	-	$ 86.2 M	USA
Acer Therapeutics ACER	0.41	-	2.71 %	$ 14 M	USA
Advaxis ADXS	5.93	-	-9.65 %	$ 45.9 M	USA
Compugen Ltd. CGEN	7.46	$ 2.14	2.39 %	$ 200 M	Israel
Ayala Pharmaceuticals AYLA	6.43	-	-	$ 7.46 M	Israel
AbCellera Biologics ABCL	3.48	$ 3.45	1.47 %	$ 1.03 B	Canada
Atreca BCEL	2.02	-	-11.76 %	$ 5.79 M	USA
BioDelivery Sciences International BDSI	2.37	-	-4.8 %	$ 255 M	USA
BeiGene, Ltd. BGNE	2.14	-	0.49 %	$ 251 B	Cayman-islands
Calithera Biosciences CALA	4.13	-	-10.95 %	$ 876 K	USA
Harmony Biosciences Holdings HRMY	3.17	$ 28.15	1.55 %	$ 1.62 B	USA
Cara Therapeutics CARA	1.83	-	-3.03 %	$ 260 M	USA
Heron Therapeutics HRTX	1.06	$ 0.8	3.3 %	$ 133 M	USA
ChemoCentryx CCXI	3.05	-	-	$ 3.74 B	USA
Bellerophon Therapeutics BLPH	1.47	-	-74.18 %	$ 955 K	USA
Coherus BioSciences CHRS	1.31	$ 1.57	2.96 %	$ 184 M	USA
Checkpoint Therapeutics CKPT	0.372	-	-	$ 169 M	USA
Clovis Oncology CLVS	0.629	-	-7.23 %	$ 13 M	USA
Aeglea BioTherapeutics AGLE	12.4	-	-	$ 1.01 B	USA
CureVac N.V. CVAC	2.47	-	-	$ 867 M	Germany
Immunovant IMVT	11.3	$ 23.9	4.0 %	$ 3.62 B	USA
Incyte Corporation INCY	3.89	$ 92.2	1.56 %	$ 18 B	USA
Akero Therapeutics AKRO	10.9	-	-	$ 3.67 B	USA
InMed Pharmaceuticals INM	7	$ 0.79	-3.39 %	$ 1.93 M	Canada
INmune Bio INMB	3.02	$ 1.17	-	$ 21 M	USA
Arbutus Biopharma Corporation ABUS	3.76	$ 4.51	6.37 %	$ 748 M	Canada